自動細胞影像系統市場規模、佔有率及成長分析（按產品/服務、應用、技術、最終用戶和地區）－2025 年至 2032 年產業預測

自動化細胞成像系統市場規模預計在 2023 年達到 1,274.8 億美元，並將從 2024 年的 1,379.3 億美元成長到 2032 年的 2,591.1 億美元，預測期內（2025-2032 年）的複合年成長率為 8.2%。

受全球慢性病盛行率上升以及藥物和疫苗研發投資增加的推動，自動化細胞成像系統市場預計將強勁成長。然而，維護成本高、備件有限等挑戰可能會阻礙市場擴張。目前，北美憑藉其早期採用的先進醫療保健技術佔據市場主導地位，而美國在該領域處於領先地位。與此同時，亞太地區在醫療基礎設施大量投資的推動下正在經歷快速成長。總體而言，成長機會充滿希望，但重要的是解決現有的挑戰以維持自動化細胞成像系統市場的發展勢頭。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局

自動細胞影像系統市場規模（依產品/服務及複合年成長率）(2025-2032)

• 市場概覽
• 裝置
• 耗材
• 軟體
• 服務

自動細胞成像系統市場規模（按應用和複合年成長率） (2025-2032)

• 市場概覽
• 藥物研發
• 診斷
• 生物和生物醫學研究
• 其他用途

自動細胞影像系統市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• 螢光影像
• 明場影像
• 高內涵篩檢
• 其他技術

自動細胞成像系統市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 製藥和生物技術公司
• 學術研究所
• 醫院
• 診斷實驗室
• 其他最終用戶

自動細胞影像系統市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• General Electric Company（USA）
• Olympus Corporation（Japan）
• PerkinElmer Inc.（USA）
• Sartorius AG（Germany）
• Thermo Fisher Scientific Inc.（USA）
• West Medica（Austria）
• Norma Diagnostika GmbH（Germany）
• BioView Ltd.（Israel）
• Caliber ID（USA）
• Molecular Devices, LLC（USA）
• Nikon Corporation（Japan）
• Leica Microsystems GmbH（Germany）
• Carl Zeiss AG（Germany）
• Agilent Technologies, Inc.（USA）
• Becton, Dickinson and Company（USA）
• Merck KGaA（Germany）
• Tecan Group Ltd.（Switzerland）
• Danaher Corporation（USA）

結論和建議

Automated Cell Imaging System Market size was valued at USD 127.48 billion in 2023 and is poised to grow from USD 137.93 billion in 2024 to USD 259.11 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).

The market for automated cell imaging systems is poised for robust growth, fueled by rising chronic disease prevalence globally and increased investment in drug and vaccine research and development. However, challenges such as high maintenance costs and limited spare parts availability may hinder market expansion. North America currently dominates the market, driven by early adoption of advanced healthcare technologies, with the USA leading in this sector. Meanwhile, the Asia-Pacific region is experiencing rapid growth, attributed to significant investments in healthcare infrastructure. Overall, while opportunities for growth are promising, addressing the existing challenges will be crucial to sustaining momentum in the automated cell imaging system market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Automated Cell Imaging System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Automated Cell Imaging System Market Segments Analysis

Global Automated Cell Imaging System Market is segmented by Product, Application, Technology, End User and region. Based on Product, the market is segmented into Instruments, Consumables, Software and Services. Based on Application, the market is segmented into Drug Discovery, Diagnostics, Biological and Biomedical Research and Other Applications. Based on Technology, the market is segmented into Fluorescence Imaging, Brightfield Imaging, High-Content Screening and Other Technologies. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals, Diagnostic Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Automated Cell Imaging System Market

The Automated Cell Imaging System market is significantly driven by the rising incidence of genetic deformities caused by lifestyle changes and radiation exposure, which can lead to irregular cell division and tumor development. Additionally, contamination of water, food, and soil with certain chemicals contributes to cancer prevalence. The emergence of new cancer types necessitates advanced imaging technologies to study the dynamics and functions of telomeric repeat-containing RNA, underscoring the importance of automated cell imaging systems. These systems have become essential tools in cellular research, enabling scientists to analyze digital microscopic images of cancerous cells with precision and efficiency, thereby propelling market growth.

Restraints in the Automated Cell Imaging System Market

The Automated Cell Imaging System market faces significant restraints due to the high costs associated with both spare parts and initial setup. When components of these systems become damaged, they often need to be fully replaced, leading to substantial expenses, exacerbated by the limited number of manufacturers available, which creates a supply deficit. Additionally, the initial investment necessary to establish such systems can be quite steep, coupled with the requirement for considerable electricity to operate them. These factors combined present notable challenges for market growth and limit accessibility for many potential users.

Market Trends of the Automated Cell Imaging System Market

The Automated Cell Imaging System market is witnessing significant growth driven by a surge in research and development of new drugs, as major pharmaceutical companies increasingly invest in advanced technologies. This trend is fueled by the need for high-throughput screening and precise analysis in drug discovery, as these systems minimize human error and reduce the time required for interventions in lengthy experiments involving extensive chemical libraries. By acquiring and analyzing high-resolution images, automated cell imaging systems enhance the efficiency and accuracy of research processes, thereby accelerating the development of innovative vaccines and therapeutics and positioning themselves as indispensable tools in modern biomedical research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Automated Cell Imaging System Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Instruments
• Consumables
• Software
• Services

Global Automated Cell Imaging System Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Diagnostics
• Biological and Biomedical Research
• Other Applications

Global Automated Cell Imaging System Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Fluorescence Imaging
• Brightfield Imaging
• High-Content Screening
• Other Technologies

Global Automated Cell Imaging System Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals
• Diagnostic Laboratories
• Other End Users

Global Automated Cell Imaging System Market Size & CAGR (2025-2032)

• North America (Product & Service, Application, Technology, End User)
  • US
  • Canada
• Europe (Product & Service, Application, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Application, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Application, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Application, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• General Electric Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Medica (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norma Diagnostika GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioView Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caliber I.D. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Devices, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Microsystems GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations